Genetic-Testing Startup 23andMe Seeks to Raise $150 Million - (Bloomberg via NewsPoints Desk)

  • 23andMe is looking to raise $150 million as the company moves into developing its own drugs, Bloomberg reported Tuesday.
  • The company has so far raised $79 million in the funding round, according to a regulatory filing.
  • 23andMe reportedly declined to comment on what the funds would be used for or who had invested.
  • In March, the company said it would expand from screening people for diseases into research and early-stage drug discovery, finding new targets for drugs from its database of consumers’ genetic and health information.

To read more NewsPoints articles, click here.